Application

18148807 · TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

Filed 2022-12-30 · Pending The official file ↗ · Art unit 1646 · Examiner Peter J Reddig Typical · CPC A61P 35/00 · The Trustees of the University of Pennsylvania · K&L Gates - Novartis

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

20.0 mo

to disposition n/a

Statutes raised

112 DP

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.